| Code | 9617C | ||||||||||
| MA number | 68/0363/18-S | ||||||||||
| Product Form: | tbl 500x100 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.11.2018 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Tiaprid FMK 100 mg_05-2025.pdf
|
| PIL: |
PIL_Tiaprid FMK 100 mg_05-2025.pdf
|
| Safety feature | Yes |
| Data update: | 31.07.2023 |
